HomeTrust Bancshares, Inc. (HTB)
Live price chart, market sentiment, and community perspectives for HomeTrust Bancshares, Inc. (NYSE: HTB).
Live price chart, market sentiment, and community perspectives for HomeTrust Bancshares, Inc. (NYSE: HTB).
On our desk, the 4% pullback in HTB shares following the $448 million Blue Ridge announcement looks like a classic knee-jerk reaction to near-term dilution fears rather than a reflection of long-term fundamentals. Creating a $7 billion Southeast bank with 60+ locations gives them critical mass in Virginia. If they execute on the cost savings, that projected 30% 2027 EPS accretion will easily justify the 8.3% TBV dilution.
Looking at the Q2 numbers, a net income of $15.6M and diluted EPS of $0.94, down slightly from Q1's $0.99, shows minor compression, but the NIM actually expanded to 4.41%. We are keeping a close eye on the rising provision for credit losses, which ticked up to $920K from $370K. Credit risk is still manageable, but integration execution will dictate whether the multiple holds up.
From a valuation standpoint, AAII flags HTB as potentially overvalued given its price relative to fundamentals, but sell-side sentiment remains aggressive. Stephens just bumped their price target to $57 with an overweight rating, pointing to a potential 22% upside from previous closes. We see strong institutional backing supporting the current multiple despite the broader banking sector crosscurrents.
As a portfolio manager tracking Southeast community banks transitioning into commercial relationship lenders, HTB's shift away from traditional thrift operations continues to pay off. Their ROA at 1.46% and ROE at 10.44% in Q2 place them ahead of many regional peers. The expansion into attractive Virginia markets is strategically sound if cultural integration succeeds.
Hedging with Q4 put spreads on regional bank baskets right now makes sense given the execution risk of absorbing Blue Ridge Bankshares. While HomeTrust is funding this entirely through an all-stock deal issuing 0.086 shares per BRBS share, keeping existing shareholders at roughly 65% ownership helps mitigate leverage risks, but integration timelines are tight.
Explore plasma cleansing, somatic organ swaps, and BCI.